cadisegliatin — Conference presentation
Q4 2026
Company to host Key Opinion Leader (KOL) event in the fourth quarter of 2026 highlighting cadisegliatin and its potential in people with T1DSource filing
VTV THERAPEUTICS INC · Data as of 2026-09-08
Q4 2026
Company to host Key Opinion Leader (KOL) event in the fourth quarter of 2026 highlighting cadisegliatin and its potential in people with T1DSource filing